StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.12 (+2.91%)

Close on Nov 17, 2026Market cap $1.31BP/E –Yield –

MannKind pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

MannKind's pe ratio was 141.5× on Apr 30, 2026, against 50.4× a year earlier. Over the last 3 years it ranged from 0.6× to 164.0×, with a median of 50.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 2026141.5×+84.8
2025Dec 31, 202556.7×−23.7
2024Dec 31, 202480.4×+77.9
2017Oct 31, 20172.4×–

More MannKind figures

See a number that looks wrong?